Medidata to Present at Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Feb 19, 2019--Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.Rouven Bergmann, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, Feb. 27, 2019, in San Francisco at 2:05 p.m. PT (5:05 p.m. ET). Dr. Bergmann will also present at the 8th Annual SVB Leerink Global Healthcare Conference on Friday, March 1, 2019, in New York at 11:00 a.m. ET.
A live audio webcast and replay of each presentation will be available at http://investor.mdsol.com.
Medidata is leading the digital transformation of life sciences, with the world’s most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata serves more than 1,000 customers and partners worldwide and empowers more than 100,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.medidata.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20190219005017/en/
CONTACT: Medidata Solutions Contacts:
Erik Snider, 646-362-2997
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT SOFTWARE HEALTH BIOTECHNOLOGY CLINICAL TRIALS MEDICAL DEVICES PHARMACEUTICAL OTHER HEALTH PROFESSIONAL SERVICES BANKING FINANCE RESEARCH SCIENCE
Copyright Business Wire 2019.
PUB: 02/19/2019 08:30 AM/DISC: 02/19/2019 08:30 AM